Amicus Therapeutics, Inc. (FOLD)
$14.49+0.00%Close
BUYBULL · day 98
Key stats
- Market cap
- $4.5B
- Avg volume
- 4.2M
- Beta
- 0.48
- P/E (TTM)
- -163.73
- 1W
- +0.21%
- 1M
- +0.42%
- 3M
- +1.40%
- YTD
- +1.54%
- vs SPY 1W
- +1.40%
- vs SPY 1M
- -2.91%
- vs SPY 3M
- -0.99%
- vs SPY YTD
- -10.21%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ACRVBUYAcrivon Therapeutics, Inc. Common StockRECOVERYQ -15$2.20-0.45%
- ALXOSELLALX Oncology Holdings Inc.RECOVERYQ -11$1.99-2.45%
- AMLXBUYAmylyx Pharmaceuticals, Inc.RECOVERYQ 10$38.15-1.32%
- BCAXSELLBicara Therapeutics Inc. Common StockCRISISQ 0$23.58-1.34%
- CRVSBUYCorvus Pharmaceuticals, Inc.RECOVERYQ 14$14.09-2.56%
- DMACSELLDiaMedica Therapeutics Inc.RECOVERYQ 6$6.52+0.00%
- DSGNBUYDesign Therapeutics, Inc.BULLQ -10$15.23+1.60%
- DYNBUYDyne Therapeutics, Inc.BULLQ 8$25.99-0.42%
- EOLSBUYEvolus, Inc.BULLQ 11$8.78+4.65%
- EWTXBUYEdgewise Therapeutics, Inc.RECOVERYQ 18$44.72+1.22%
- IMUXBUYImmunic, Inc.BULLQ -5$16.46-0.24%
- KRMDSELLKORU Medical Systems, Inc.CRISISQ 19$3.22+0.31%
Industry peers
FMP comparable companies · ranked by market cap
- SRRKBUYScholar Rock Holding Corporation$7.0BRECOVERYQ 25$58.20+3.01%
- KNSABUYKiniksa Pharmaceuticals International, plc$6.0BBULLQ 23$79.38+0.44%
- CDTXCidara Therapeutics, Inc.$5.6B$221.38
- ADPTSELLAdaptive Biotechnologies Corporation$4.1BRECOVERYQ 6$25.55-1.69%
- LEGNBUYLegend Biotech Corporation$3.9BRECOVERYQ 4$20.94-4.03%
- CPRXBUYCatalyst Pharmaceuticals, Inc.$3.9BBULLQ 20$31.49+0.00%
- IDYABUYIDEAYA Biosciences, Inc.$3.8BBULLQ 26$40.04+0.93%
- TARSBUYTarsus Pharmaceuticals, Inc.$3.1BRECOVERYQ 24$72.81+0.15%
- ARQTSELLArcutis Biotherapeutics, Inc.$3.1BRECOVERYQ 10$24.78-1.20%
- MLYSSELLMineralys Therapeutics, Inc.$2.2BRECOVERYQ 21$25.27-1.48%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 19
- VALUE
- 3
- GROWTH
- 43
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-7.2%
REV YoY-
ROE-12.0%
EPS YoY-
ROA-2.9%
GROSS88
OP5
NET-4
[VALUATION]
P/E TTM-163.73
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B16.33
P/FCF-
EV/EBITDA89.56
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E176.24
ALTMAN Z-
CURR RATIO2.84
ND/EBITDA-
BETA0.48
